G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)

Market Cap	3.24B
Revenue (ttm)	249.03M
Net Income (ttm)	102.06M
Shares Out	59.00M
EPS (ttm)	1.73
PE Ratio	31.74
Forward PE	n/a
Dividend	0.76 (1.40%)
Ex-Dividend Date	n/a

Volume	23,118
Average Volume	31,939
Open	54.90
Previous Close	54.90
Day's Range	54.50 - 54.90
52-Week Range	48.58 - 61.70
Beta	-0.23
RSI	39.06
Earnings Date	Mar 21, 2025

About G&E Herbal Biotechnology

G&E Herbal Biotechnology Co., Ltd. engages in development and commercialization of novel botanical extraction technology and products. It offers Hepanamin capsules; botoniocal healthcare products; botanical anti-aging cosmetics, which includes facial cleansing essence, botonic extract toner, moisturizing cream and serum, and essential oil; smile cream and topical gel; and adult products, including lubricants. G&E Herbal Biotechnology Co., Ltd. was founded in 2002 and is based in Tainan City, Taiwan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 39
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4911

Financial Performance

In 2024, G&E Herbal Biotechnology's revenue was 249.03 million, an increase of 37.25% compared to the previous year's 181.44 million. Earnings were 102.06 million, an increase of 40.97%.